Consonance Capital Management LP Legend Biotech Corp Transaction History

Consonance Capital Management LP

  • $7.28 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$35.31 - $50.56 $58.2 Million - $83.3 Million
-1,647,497 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$25.8 - $41.09 $19.4 Million - $30.9 Million
750,889 Added 83.75%
1,647,497 $67.6 Million
Q1 2021

May 17, 2021
BUY
$23.55 - $32.4 $21.1 Million - $29.1 Million
896,608 New
896,608 $26 Million

Others Institutions Holding LEGN

# of Institutions
198
Shares Held
74.2M
Call Options Held
374K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.5B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Consonance Capital Management LP Portfolio

Follow Consonance Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Consonance Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email